Breakthrough in Ebola Vaccination: Five-Year Immunity Achieved After Injection
A decisive new step has been taken in the fight against the Ebola virus. According to a PREVAC study conducted in Guinea, the immunity conferred by three experimental
A decisive new step has been taken in the fight against the Ebola virus. According to a PREVAC study conducted in Guinea, the immunity conferred by three experimental
The waste of two essential items in the healthcare and nutritional response in sub-Saharan Africa poses significant environmental pollution. How can their impact be minimized? Addressing this issue
Collaboration between researchers and humanitarians is key to transforming medicine in Africa. Our new web series explores how these professionals are working hand in hand to address health
Nearly two years after publishing its environmental roadmap, ALIMA presents its first progress report with achievements and lessons learned since 2021. By sharing the report, the medical NGO
Nigeria enters Lassa fever peak season with new outbreaks underway Abuja, Nigeria, 27 February 2024 – A first-of-its-kind global alliance of researchers, humanitarians, and health workers called the
Hypoxemia is a little-known, clinically underdiagnosed medical complication. Often associated with common illnesses in children under five, it can be fatal. For example, it is the most prevalent
ALIMA, AAH, IRC and UNICEF invited representatives from the health ministries of nine countries in West and Central Africa to a conference in Dakar to discuss innovative “simplified
The results of a large-scale clinical trial in West Africa, confirming the safety of three different Ebola vaccine regimens, have been published in the New England Journal of
The “Breath for All” project, made possible by the financial support of Unitaid, is a new project developed by ALIMA to improve access to oxygen in Mali, Guinea,
Results of a randomized clinical trial conducted in the Kasai province of the Democratic Republic of Congo (DRC) were published today in the medical journal The Lancet Global
For the United States: 100% of your donation will be tax-deductible. ALIMA USA, Inc., is recognized as tax-exempt under section 501(c)(3) of the Internal Revenue Code. EIN: 26-0397519.
For France: Association Law 1901 – Registration and SIREN number : 831 620 398
Under the French tax system, you will benefit from an income tax reduction of 75% of the amount of your donations up to a maximum of 1 000 euros. Beyond that amount, donations are 66% tax deductible up to an equivalent of 20% of your taxable income.
By subscribing to the ALIMA newsletter, you agree to receive information from us. You can unsubscribe at any time using the unsubscribe links. To understand the use of your data collected by this form, please consult our privacy policy.
Subscribe to our monthly newsletter
By subscribing to the ALIMA newsletter, you agree to receive information from us. You can unsubscribe at any time using the unsubscribe links. To understand the use of your data collected by this form, please consult our privacy policy.
For the United States: 100% of your donation will be tax-deductible. ALIMA USA, Inc., is recognized as tax-exempt under section 501(c)(3) of the Internal Revenue Code. EIN: 26-0397519.
For France: Association Law 1901 – Registration and SIREN number : 831 620 398
Under the French tax system, you will benefit from an income tax reduction of 75% of the amount of your donations up to a maximum of 1 000 euros. Beyond that amount, donations are 66% tax deductible up to an equivalent of 20% of your taxable income.
Please wait while you are redirected to the right page...